Chimeric Therapeutics Ltd Financial Flexibility Index
Chimeric Therapeutics Ltd financial flexibility index. Chimeric Therapeutics Ltd (CHM) has a Financial Flexibility Index of -0.43x as of December 2025. Free cash flow of AU$-3.84 Million (operating CF AU$-3.84 Million minus capex AU$5.00) represents 0% of total liabilities (AU$8.96 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Chimeric Therapeutics Ltd (2020–2025)
Financial flexibility index of Chimeric Therapeutics Ltd from 2020 to 2025. Historical Financial Flexibility Index trend for Chimeric Therapeutics Ltd across 6 annual periods. Check CHM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Chimeric Therapeutics Ltd Financial Flexibility Index by Year (2020–2025)
Chimeric Therapeutics Ltd financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Chimeric Therapeutics Ltd. For the full cash flow conversion analysis, see Chimeric Therapeutics Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.37x | AU$-7.28 Million | AU$-7.28 Million | AU$19.60 Million | ▼ -47103.4% |
| 2024 | 0.00x | AU$10.11K | AU$-7.54 Million | AU$12.80 Million | ▲ +100.1% |
| 2023 | -0.97x | AU$-16.20 Million | AU$-16.32 Million | AU$16.71 Million | ▲ +29.5% |
| 2022 | -1.38x | AU$-12.62 Million | AU$-13.15 Million | AU$9.17 Million | ▼ -342.4% |
| 2021 | -0.31x | AU$-3.54 Million | AU$-8.84 Million | AU$11.37 Million | ▼ -12.1% |
| 2020 | -0.28x | AU$-17.75K | AU$-34.01K | AU$64.01K | — |